21 Jun 2022 Animated Videos Darolutamide and survival in metastatic, hormone-sensitive prostate cancer: a plain language summary of the ARASENS trial
10 May 2022 Animated Videos A qualitative research study in Japan investigating patients’ experience with metastatic castration-resistant prostate cancer
12 Apr 2022 Oncology & Hematology TALAPRO-2: talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer
6 Apr 2022 Neurology & Psychiatry A pregnancy register cohort study among women with MS in Finland and Sweden
28 Mar 2022 Oncology & Hematology INSIGHT 2: a phase II study of tepotinib plus osimertinib in MET-amplified NSCLC and first-line osimertinib resistance
9 Mar 2022 Cell & Gene Therapy Ataluren delays loss of ambulation and respiratory decline in nonsense mutation Duchenne muscular dystrophy patients
22 Nov 2021 Rare Diseases Plain language summary: Vosoritide treatment accelerates bone growth in children with achondroplasia
16 Aug 2021 Dermatology When should a PCP refer a patient with pustular psoriasis to a dermatologist?
16 Aug 2021 Dermatology When should a PCP refer a patient with pustular psoriasis to a dermatologist?
21 May 2020 Neurology & Psychiatry Molecular imaging of tau pathology after traumatic brain injury with Nikos Gorgoraptis
22 Nov 2021 Rare Diseases Plain language summary: Vosoritide treatment accelerates bone growth in children with achondroplasia
14 Feb 2020 Oncology & Hematology Outcomes of first-line pembrolizumab monotherapy for PD-L1–positive (TPS ≥50%) metastatic NSCLC at US oncology practices
21 Apr 2020 Oncology & Hematology Adverse events in women switching from olaparib capsules to tablets: Retrospective observational study of US claims data
15 Dec 2020 Nanomedicine & Nanotechnology The promise of nanomedicine research with Sourav Bhattacharjee
